We are live on ! Find out more
HURA

TuHURA Biosciences

2 hedge funds and large institutions have $89K invested in TuHURA Biosciences in 2019 Q2 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more ownership

Funds ownership: 0%0% (+0%)

75% less funds holding

Funds holding: 82 (-6)

77% less capital invested

Capital invested by funds: $391K → $89K (-$302K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 6

Holders
2
Holders Change
-6
Holders Change %
-75%
% of All Funds
0.04%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
Closed
6
Calls
Puts
Net Calls
Net Calls Change

HURA Hedge Fund Activity: Q2 2019 in Review

2 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q2 2019, worth a combined $89K — down 77% from $391K a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of HURA and 0 opened new positions — a net loss of 6 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was Virtu Financial, adding an estimated $146K. The largest seller was Sabby Management, exiting entirely with an estimated $243K sold.

  • 2 institutional investors held TuHURA Biosciences (HURA) as of Q2 2019, down from 8 in Q1 2019.
  • Funds reported $89K of TuHURA Biosciences stock for Q2 2019, down 77% quarter-over-quarter.
  • 0 funds opened new TuHURA Biosciences positions in Q2 2019 and 6 closed out, a net change of -6 holders.
  • The largest TuHURA Biosciences buyer in Q2 2019 was Virtu Financial, an estimated $146K added.
  • The largest TuHURA Biosciences seller in Q2 2019 was Sabby Management, an estimated $243K sold.

Based on aggregated 13F filings for Q2 2019.